ASND insider filings
Ascendis Pharma A/S — 9 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-09-28. Screen ASND transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 4 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing by 1 insider — 2,000 shares, $492,654 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings by 2 insiders — 3,236 shares, $872,905 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 3,000 shares @ $270.19 ($810,570) by Bodenhoff Mads, filed 2026-09-09.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Bodenhoff Mads — SVP & PAO | 1 | — | 1 leg · 3,000 sh · $810,570 | 2 |
| BIENAIME JEAN JACQUES — Director | 2 | 2 legs · 2,000 sh · $492,654 | — | 2 |
| HOLTUG LARS — Director | 1 | — | 1 leg · 236 sh · $62,335 | — |
Recent insider filings — Ascendis Pharma A/S
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-28 | 4 | BIENAIME JEAN JACQUES — Director | Disposition to issuer (D): 9,160 (derivative) · Grant/award (A): 9,160 (derivative) | EDGAR |
| 2026-09-09 | 4 | Bodenhoff Mads — SVP & PAO | Option exercise (M): 3,000 @ $110 · Sale (S): 3,000 @ $270.19 · Option exercise (M): 3,000 (derivative) @ $0 | EDGAR |
| 2026-09-03 | 4 | HOLTUG LARS — Director | Sale (S): 236 @ $264.13 | EDGAR |
| 2026-08-18 | 4 | BIENAIME JEAN JACQUES — Director | Purchase (P): 1,100 @ $245.85 · Purchase (P): 900 @ $246.91 | EDGAR |
| 2026-06-02 | 4 | SMITH SCOTT THOMAS — EVP & Chief Financial Officer | Purchase (P): 100 @ $219 | EDGAR |
| 2026-06-01 | 4 | SMITH SCOTT THOMAS — EVP & Chief Financial Officer | Purchase (P): 250 @ $223.32 | EDGAR |
| 2026-06-01 | 4 | BIENAIME JEAN JACQUES — Director | Purchase (P): 200 @ $223.76 · Purchase (P): 200 @ $222.30 · Purchase (P): 100 @ $223.50 | EDGAR |
| 2026-05-27 | 4 | BIENAIME JEAN JACQUES — Director | Purchase (P): 200 @ $236.24 · Purchase (P): 200 @ $239.37 | EDGAR |
| 2026-05-12 | 4 | JENSEN FLEMMING STEEN — See Remarks | Sale (S): 19,460 @ $238.49 | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=ASND returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →